Skip to main content
. 2013 Jun 27;7(6):e2258. doi: 10.1371/journal.pntd.0002258

Figure 4. Distribution of the patients according to the interval between exposure and treatment.

Figure 4

Distribution of the 20 patients according to the intervals between exposure and D0 (beginning of postexposure prophylaxis), D0 and D7, D7 and D21, and last active dose and serology (Elaé, Kayodé, December 2010–June 2011). * Patients with anti-rabies–antibody titers. † Serology and vaccination at the same time.